Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Alan Simon Pickard

Alan Simon Pickard


Professor, College of Pharmacy - Pharmacy Systems Outcomes and Policy
Interim Associate Head, PSOP
Assistant Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research

About Heading link

Overview:
A. Simon Pickard, PhD, is a Professor and Director of Graduate Studies in the Department of Pharmacy Systems, Outcomes and Policy, and Co-Director of the Center for Pharmacoepidemiology and Pharmacoeconomic Research at the University of Illinois at Chicago’s College of Pharmacy. He earned his B.Comm., B.Sc. in Pharmacy, and PhD in Pharmacy and Pharmaceutical Sciences from the University of Alberta in Edmonton, Alberta, Canada. Dr. Pickard has authored over 150 publications on evaluating the safety, effectiveness and value of health care interventions; improving drug-related outcomes through education (particularly opioids); and on the measurement and evaluation of quality of care and health outcomes. He has served on several editorial boards, including Medical Decision Making, Drugs in Context, and Quality of Life Research. He is co-developer of the LupusPRO, a lupus specific quality of life measure. He has extensively contributed to the EuroQol Group, developers of the EQ-5D, one of the most widely used measures of health in clinical trials throughout the world, and is part of the international consortia to develop a new measure of health and well-being (EQ-HWB).

Research Interests:
Dr. Pickard’s research interests involve evaluating the safety, effectiveness and value of health care interventions; improving drug-related outcomes through education (particularly opioids); and on the measurement and evaluation of quality of care and health outcomes. H

Teaching Statement:
Dr. Pickard is an educator in the UIC professional program (PharmD) and graduate program (PhD/MS). In the PharmD program, he is creating a an elective course that provides an overview of health economic and outcomes research (HEOR) to be available starting Fall 2022. He serves as preceptor for P4 PharmD students in advanced clerkships rotations offered each year. In the PhD program for PSOP, he teaches the measurement and evaluation of patient-reported outcomes (PSOP 555) and introduction to comparative effectiveness research (PSOP 516). He serves as main advisor for PhD/MS students, and as a committee member on department qualifiers, preliminary exams and dissertation defenses. He has served as a director for numerous (post-doc) fellowships in partnership with industry since 2007, including TAP, Takeda, NovoNordisk, and Pfizer.

Teaching and Supervision Heading link

Hlth Econ & Outcomes Research (PSOP 489), 8/22/2022 – 12/2/2022
Ph.D. Thesis Research (PSOP 599), 8/22/2022 – 12/2/2022
Independent Study (PSOP 596), 8/22/2022 – 12/2/2022
Ph.D. Thesis Research (PSOP 599), 1/10/2022 – 4/29/2022
Independent Study (PSOP 596), 1/10/2022 – 4/29/2022
Comp Effectiveness Research (PSOP 516), 1/10/2022 – 4/29/2022
Ph.D. Thesis Research (PSOP 599), 8/23/2021 – 12/3/2021
Independent Study (PSOP 596), 8/23/2021 – 12/3/2021
Social and Behavioral Pharmacy (PHAR 462), 8/23/2021 – 10/29/2021

Selected Grants

Pfizer 2022 to 2025 Fellowship - Pickard, Pfizer Inc., 7/1/2022 - 6/30/2025, Obligated Amount: $482934; Anticipated Amount: $482934

Self-perceived burden, caregiver burden and EQ measures �assessing measurement overlap, EuroQol Group., 5/1/2022 - 5/1/2023, Obligated Amount: $137909; Anticipated Amount: $137909

UIC Prescription Monitoring Academic Detailing - contract 49I1127M40, Illinois Department of Human Services., 12/30/2020 - 8/31/2023, Obligated Amount: $510000; Anticipated Amount: $510000

OD2A Year 2 and 3 Evaluation IGA, Illinois Department of Public Health., 9/1/2020 - 8/31/2022, Obligated Amount: $600000; Anticipated Amount: $600000

PhD dissertation funding request for a novel valuation method, Euroqol Group Business Mgmt., 8/16/2020 - 8/15/2022, Obligated Amount: $50163; Anticipated Amount: $50163

Pilot Project for Academic Detailing, Illinois Department of Public Health., 7/1/2020 - 6/30/2021, Obligated Amount: $110000; Anticipated Amount: $110000

2020 - 2021 Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical and Economic Review., 1/1/2020 - 12/31/2021, Obligated Amount: $425000; Anticipated Amount: $425000

Impacting the Prescribing of Opioids through Academic Detailing, US Centers for Disease Control and Prevention., 9/30/2019 - 9/29/2023, Obligated Amount: $2297565; Anticipated Amount: $2297565

Impacting the Prescribing of Opioids through Academic Detailing, National Center for Injury Prevention and Control., 9/30/2019 - 9/29/2022, Obligated Amount: $2297565; No Anticipated Amount Set

Selected Publications

Jiang, R, Rand, K, Kuharic, M, Pickard, AS. (2022). EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets. Health and Quality of Life Outcomes, 20, (1). doi:10.1186/s12955-022-02031-8.

McTaggart-Cowan, H, King, MT, Norman, R, Costa, DSJ, Pickard, AS, Viney, R, Peacock, SJ, Chan, K, Hoch, J, Leighl, N, Mittmann, N, Regier, D. (2022). The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study. Health and Quality of Life Outcomes, 20, (1). doi:10.1186/s12955-022-02002-z.

Brazier, John, Peasgood, Tessa, Mukuria, Clara, Luo, Nan, Mulhern, Brendan, Pickard, A Simon, Augustovski, Federico, Greiner, Wolfgang, Engel, Lidia. (2022). Author Reply to “Measuring Health and Well-Being: We Need to Get it Right for Patients With Patients”. Value in Health. doi:10.1016/j.jval.2022.10.010.

Chaudhuri, KR, Pickard, AS, Alobaidi, A, Jalundhwala, YJ, Kandukuri, PL, Bao, Y, Sus, J, Jones, G, Ridley, C, Oddsdottir, J, Najle-Rahim, S, Madin-Warburton, M, Xu, W, Schrag, A. (2022). The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England. PharmacoEconomics, 40, (5), 559-574. doi:10.1007/s40273-022-01132-y.

Brazier, J, Peasgood, T, Mukuria, C, Marten, O, Kreimeier, S, Luo, N, Mulhern, B, Pickard, AS, Augustovski, F, Greiner, W, Engel, L, Belizan, M, Yang, Z, Monteiro, A, Kuharic, M, Gibbons, L, Ludwig, K, Carlton, J, Connell, J, Rand, S, Devlin, N, Jones, K, Tsuchiya, A, Lovett, R, Naidoo, B, Rowen, D, Rejon-Parrilla, JC. (2022). The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results. Value in Health, 25, (4), 482-491. doi:10.1016/j.jval.2022.01.009.

Monteiro, AL, Kuharic, M, Pickard, AS. (2022). A Comparison of a Preliminary Version of the EQ-HWB Short and the 5-Level Version EQ-5D. Value in Health, 25, (4), 534-543. doi:10.1016/j.jval.2022.01.003.

Peasgood, T, Mukuria, C, Brazier, J, Marten, O, Kreimeier, S, Luo, N, Mulhern, B, Greiner, W, Pickard, AS, Augustovski, F, Engel, L, Gibbons, L, Yang, Z, Monteiro, AL, Kuharic, M, Belizan, M, Bjørner, J. (2022). Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB. Value in Health, 25, (4), 525-533. doi:10.1016/j.jval.2021.11.1361.

Grivas, Petros, Barata, Pedro C, Moon, Helen, Hutson, Thomas E, Gupta, Shilpa, Sternberg, Cora N, Pickard, A Simon, Dave, Vaidehi, Han, Natalia, Shillington, Alicia C, Devgan, Geeta, Kim, Ruth, Thakkar, Sheena, Katzenstein, Howard, Bhanegaonkar, Abhijeet, Liu, Frank, Sonpavde, Guru P. (2022). PATRIOT II: An ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States.. Journal of Clinical Oncology, 40, (6_suppl), tps578-tps578. doi:10.1200/jco.2022.40.6_suppl.tps578.

Feng, YS, Jiang, R, Pickard, AS, Kohlmann, T. (2022). Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset. Quality of Life Research, 31, (1), 11-23. doi:10.1007/s11136-021-02922-1.

Education

Degrees:
Ph.D., University of Alberta, Canada, 2002
B.Sc, University of Alberta, Canada, 1996
B. Comm, University of Alberta, Canada, 1991